Preoperative checklist to reduce the risk of cardiac implantable electronic device infections.


Journal

Pacing and clinical electrophysiology : PACE
ISSN: 1540-8159
Titre abrégé: Pacing Clin Electrophysiol
Pays: United States
ID NLM: 7803944

Informations de publication

Date de publication:
Feb 2022
Historique:
revised: 03 12 2021
received: 14 08 2021
accepted: 10 12 2021
pubmed: 21 12 2021
medline: 15 3 2022
entrez: 20 12 2021
Statut: ppublish

Résumé

Cardiac implantable electronic device (CIED) infection represents a dramatic event with a high mortality rate (>3x) despite antibiotic therapy and device extraction; therefore, the real winning strategy in this situation could be represented by prevention. Antibiotic prophylaxis and antibiotic-releasing envelope are effective in improving patient outcome; however, healthcare costs related to CIED infections remain high over the years. In this review we would keep the attention on a pre-surgical checklist to reduce the risk of CIED infections. In fact, checklist is an effective instrument for medical care quality improvement mainly used in surgery, but not very commonly in cath-lab and electrophysiology procedures. All steps of this checklist are of proven effectiveness in reducing the risk of CIED infections but, up till now, they are not considered together in a pre-surgical approach.

Identifiants

pubmed: 34927271
doi: 10.1111/pace.14429
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

262-269

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

Tarakji KG, Wazni OM, Harb S, Hsu A, Saliba W, Wilkoff BL. Risk factors for 1-year mortality among patients with cardiac implantable electronic device infection undergoing transvenous lead extraction: the impact of the infection type and the presence of vegetation on survival. Europace. 2014;16:1490-1495.
Wilkoff BL, Boriani G, Mittal S, et al. Impact of cardiac implantable electronic device infection: a clinical and economic analysis of the WRAP-IT Trial. Circ Arrhythm Electrophysiol. 2020;13:e008280.
Krahn AD, Longtin Y, Philippon F, et al. Prevention of arrhythmia device infection trial: the PADIT trial. J Am Coll Cardiol. 2018;72:3098-3109.
Tarakji KG, Mittal S, Kennergren C, et al. Antibacterial envelope to prevent cardiac implantable device infection. N Engl J Med. 2019;380:1895-1905.
Protocollo di monitoraggio degli eventi sentinella [Sentinel Event Monitoring Protocol] - 5° Rapporto (settembre 2005-dicembre 2012), (ed 2015/04/23), 2015. www.salute.gov.it
Haynes AB, Weiser TG, Berry WR, et al. A surgical safety checklist to reduce morbidity and mortality in a global population. N Engl J Med. 2009;360:491-499.
Russ S, Rout S, Caris J, et al. Measuring variation in use of the WHO surgical safety checklist in the operating room: a multicenter prospective cross-sectional study. J Am Coll Surg. 2015;220:1-11 e14.
Law No. 24/2017. Provisions on the safety of care and of the assisted person, as well as on the professional responsibility of health professionals, in Constitution I (ed.). 2, 2017
Polyzos KA, Konstantelias AA, Falagas ME. Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis. Europace. 2015;17:767-777.
Birnie DH, Wang J, Alings M, et al. Risk factors for infections involving cardiac implanted electronic devices. J Am Coll Cardiol. 2019;74:2845-2854.
Mittal S, Shaw RE, Michel K, et al. Cardiac implantable electronic device infections: incidence, risk factors, and the effect of the AigisRx antibacterial envelope. Heart Rhythm. 2014;11:595-601.
Blomstrom-Lundqvist C, Traykov V, Erba PA, et al. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Europace. 2020;22:515-549.
Allegranzi B, Bischoff P, de Jonge S, et al. New WHO recommendations on preoperative measures for surgical site infection prevention: an evidence-based global perspective. Lancet Infect Dis. 2016;16:e276-e287.
Sandoe JA, Barlow G, Chambers JB, et al. Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rhythm Society (BHRS), British Cardiovascular Society (BCS), British Heart Valve Society (BHVS) and British Society for Echocardiography (BSE). J Antimicrob Chemother. 2015;70:325-359.
Katsoulas T, Kapritsou M, Alexandrou E, et al. Peripherally inserted central catheter ports: a vascular access specialist's systematic approach. J Vasc Nurs. 2019;37:113-116.
Baddour LM, Epstein AE, Erickson CC, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation. 2010;121:458-477.
Darouiche R, Mosier M, Voigt J. Antibiotics and antiseptics to prevent infection in cardiac rhythm management device implantation surgery. Pacing Clin Electrophysiol. 2012;35:1348-1360.
de Oliveira JC, Martinelli M, Nishioka SA, et al. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial. Circ Arrhythm Electrophysiol. 2009;2:29-34.
Alzahrani T, Liappis AP, Baddour LM, Karasik PE. Preoperative antibiotics and cardiovascular implantable electronic device infection: a cohort study in veterans. Pacing Clin Electrophysiol. 2018;41:1513-1518.
Boriani G, Kennergren C, Tarakji KG, et al. Cost-effectiveness analyses of an absorbable antibacterial envelope for use in patients at increased risk of cardiac implantable electronic device infection in Germany, Italy, and England. Value Health. 2021;24:930-938.
Boriani G, Vitolo M, Wright DJ, et al. Infections associated with cardiac electronic implantable devices: economic perspectives and impact of the TYRX antibacterial envelope. Europace. 2021;23:iv33-iv44.
Tarakji KG, Krahn AD, Poole JE, et al. Risk factors for CIED infection after secondary procedures: insights from the WRAP-IT Trial. JACC Clin Electrophysiol. 2021 Sep 18:S2405-500X(21)00766-0
Da Costa A, Tulane C, Dauphinot V, et al. Preoperative skin antiseptics for prevention of cardiac implantable electronic device infections: a historical-controlled interventional trial comparing aqueous against alcoholic povidone-iodine solutions. Europace. 2015;17:1092-1098.
Darouiche RO, Wall MJ, Jr., Itani KM, et al. Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N Engl J Med. 2010;362:18-26.
Qintar M, Zardkoohi O, Hammadah M, et al. The impact of changing antiseptic skin preparation agent used for cardiac implantable electronic device (CIED) procedures on the risk of infection. Pacing Clin Electrophysiol. 2015;38:240-246.
Steffel J, Collins R, Antz M, et al. 2021 European Heart Rhythm Association practical guide on the use of non-vitamin k antagonist oral anticoagulants in patients with atrial fibrillation. Europace. 2021;23:1612-1676.
Tarakji KG, Korantzopoulos P, Philippon F, et al. Infectious consequences of hematoma from cardiac implantable electronic device procedures and the role of the antibiotic envelope: a WRAP-IT trial analysis. Heart Rhythm. 2021;18:2080-2086.
Ghosh S, Stadler RW, Mittal S. Automated detection of effective left-ventricular pacing: going beyond percentage pacing counters. Europace. 2015;17:1555-1562.
Shariff N, Eby E, Adelstein E, et al. Health and economic outcomes associated with use of an antimicrobial envelope as a standard of care for cardiac implantable electronic device implantation. J Cardiovasc Electrophysiol. 2015;26:783-789.

Auteurs

Matteo Ziacchi (M)

Cardiology Unit, University of Bologna, Bologna, Italy.

Giulia Massaro (G)

Cardiology Unit, University of Bologna, Bologna, Italy.

Andrea Angeletti (A)

Cardiology Unit, University of Bologna, Bologna, Italy.

Giovanni Statuto (G)

Cardiology Unit, University of Bologna, Bologna, Italy.

Igor Diemberger (I)

Cardiology Unit, University of Bologna, Bologna, Italy.

Cristian Martignani (C)

Cardiology Unit, University of Bologna, Bologna, Italy.

Nazzareno Galiè (N)

Cardiology Unit, University of Bologna, Bologna, Italy.

Mauro Biffi (M)

Cardiology Unit, University of Bologna, Bologna, Italy.

Giuseppe Boriani (G)

Cardiology Unit, University of Modena and Reggio Emilia, Modena, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH